Obesity and renal cell cancer – a quantitative review

Obesity has been associated with an increased risk of renal cell cancer among women, while the evidence for men is considered weaker. We conducted a quantitative summary analysis to evaluate the existing evidence that obesity increases the risk of renal cell cancer both among men and women. We identified all studies examining body weight in relation to kidney cancer, available in MEDLINE from 1966 to 1998. The quantitative summary analysis was limited to studies assessing obesity as body mass index (BMI, kg m−2), or equivalent. The risk estimates and the confidence intervals were extracted from the individual studies, and a mixed effect weighted regression model was used. We identified 22 unique studies on each sex, and the quantitative analysis included 14 studies on men and women, respectively. The summary relative risk estimate was 1.07 (95% CI 1.05–1.09) per unit of increase in BMI (corresponding to 3 kg body weight increase for a subject of average height). We found no evidence of effect modification by sex. Our quantitative summary shows that increased BMI is equally strongly associated with an increased risk of renal cell cancer among men and women. © 2001 Cancer Research Campaignhttp://www.bjcancer.com

Abstract licence: CC BY-NC-SA

1. 1.

   Asal N. R., Geyer J. R., Risser D. R., Lee E. T., Kadamani S., Cherng N. Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions. Cancer Detect Prev. 1988;13(3-4):263-279.

   Not in our library

2. 2.

   Benhamou S., Lenfant M. H., Ory-Paoletti C., Flamant R. Risk factors for renal-cell carcinoma in a French case-control study. Int J Cancer. 1993;55(1):32-36.

   Not in our library10.1002/ijc.2910550107 (opens in a new tab)

3. 3.

   Benichou J., Chow W. H., McLaughlin J. K., Mandel J. S., Fraumeni J. F. Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol. 1998;148(5):424-430.

   Not in our library10.1093/oxfordjournals.aje.a009667 (opens in a new tab)

4. 4.

   Berkey C. S., Hoaglin D. C., Mosteller F., Colditz G. A. A random-effects regression model for meta-analysis. Stat Med. 1995;14(4):395-411.

   Not in our library10.1002/sim.4780140406 (opens in a new tab)

5. 5.

   Black R. J., Bray F., Ferlay J., Parkin D. M. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer. 1997;33(7):1075-1107.

   Not in our library10.1016/s0959-8049(96)00492-3 (opens in a new tab)

6. 6.

   Boeing H., Schlehofer B., Wahrendorf J. Diet, obesity and risk for renal cell carcinoma: results from a case control-study in Germany. Z Ernahrungswiss. 1997;36(1):3-11.

   Not in our library10.1007/bf01618893 (opens in a new tab)

7. 7.

   Chow W. H., Devesa S. S., Warren J. L., Fraumeni J. F. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281(17):1628-1631.

   Not in our library10.1001/jama.281.17.1628 (opens in a new tab)

8. 8.

   Chow W. H., McLaughlin J. K., Mandel J. S., Wacholder S., Niwa S., Fraumeni J. F. Obesity and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev. 1996;5(1):17-21.

   Not in our library

9. 9.

   Cole P., MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med. 1971;25(4):242-244.

   Not in our library10.1136/jech.25.4.242 (opens in a new tab)

10. 10.

    Devesa S. S., Silverman D. T., McLaughlin J. K., Brown C. C., Connelly R. R., Fraumeni J. F. Comparison of the descriptive epidemiology of urinary tract cancers. Cancer Causes Control. 1990;1(2):133-141.

    Not in our library10.1007/bf00053164 (opens in a new tab)

11. 11.

    Finkle W. D., McLaughlin J. K., Rasgon S. A., Yeoh H. H., Low J. E. Increased risk of renal cell cancer among women using diuretics in the United States. Cancer Causes Control. 1993;4(6):555-558.

    Not in our library10.1007/bf00052431 (opens in a new tab)

12. 12.

    Flegal K. M., Carroll M. D., Kuczmarski R. J., Johnson C. L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord. 1998;22(1):39-47.

    Not in our library10.1038/sj.ijo.0800541 (opens in a new tab)

13. 13.

    Frystyk J., Vestbo E., Skjaerbaek C., Mogensen C. E., Orskov H. Free insulin-like growth factors in human obesity. Metabolism. 1995;44(10 Suppl 4):37-44.

    Not in our library10.1016/0026-0495(95)90219-8 (opens in a new tab)

14. 14.

    Gamble J. F., Pearlman E. D., Nicolich M. J. A nested case-control study of kidney cancer among refinery/petrochemical workers. Environ Health Perspect. 1996;104(6):642-650.

    Not in our library10.1289/ehp.96104642 (opens in a new tab)

15. 15.

    Goodman M. T., Morgenstern H., Wynder E. L. A case-control study of factors affecting the development of renal cell cancer. Am J Epidemiol. 1986;124(6):926-941.

    Not in our library10.1093/oxfordjournals.aje.a114482 (opens in a new tab)

16. 16.

    Greenland S., Longnecker M. P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301-1309.

    Not in our library10.1093/oxfordjournals.aje.a116237 (opens in a new tab)

17. 17.

    Hall J. E. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 1994;23(3):381-394.

    Not in our library10.1161/01.hyp.23.3.381 (opens in a new tab)

18. 18.

    Heath C. W., Lally C. A., Calle E. E., McLaughlin J. K., Thun M. J. Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer. Am J Epidemiol. 1997;145(7):607-613.

    Not in our library10.1093/oxfordjournals.aje.a009157 (opens in a new tab)

19. 19.

    Hiatt R. A., Tolan K., Quesenberry C. P. Renal cell carcinoma and thiazide use: a historical, case-control study (California, USA). Cancer Causes Control. 1994;5(4):319-325.

    Not in our library10.1007/bf01804982 (opens in a new tab)

20. 20.

    Kadamani S., Asal N. R., Nelson R. Y. Occupational hydrocarbon exposure and risk of renal cell carcinoma. Am J Ind Med. 1989;15(2):131-141.

    Not in our library10.1002/ajim.4700150202 (opens in a new tab)

21. 21.

    Kellerer M., von Eye Corleta H., Mühlhöfer A., Capp E., Mosthaf L., Bock S., Petrides P. E., Häring H. U. Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int J Cancer. 1995;62(5):501-507.

    Not in our library10.1002/ijc.2910620502 (opens in a new tab)

22. 22.

    Kopelman P. G. Obesity as a medical problem. Nature. 2000;404(6778):635-643.

    Not in our library10.1038/35007508 (opens in a new tab)

23. 23.

    Kreiger N., Marrett L. D., Dodds L., Hilditch S., Darlington G. A. Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control. 1993;4(2):101-110.

    Not in our library10.1007/bf00053150 (opens in a new tab)

24. 24.

    Kuskowska-Wolk A., Karlsson P., Stolt M., Rössner S. The predictive validity of body mass index based on self-reported weight and height. Int J Obes. 1989;13(4):441-453.

    Not in our library

25. 25.

    Landis S. H., Murray T., Bolden S., Wingo P. A. Cancer statistics, 1999. CA Cancer J Clin. 1999;49(1):8-1.

    Not in our library10.3322/canjclin.49.1.8 (opens in a new tab)

26. 26.

    Lew E. A., Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis. 1979;32(8):563-576.

    Not in our library10.1016/0021-9681(79)90119-x (opens in a new tab)

27. 27.

    Li J. J., Li S. A., Oberley T. D., Parsons J. A. Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation. Cancer Res. 1995;55(19):4347-4351.

    Not in our library

28. 28.

    Lindblad P., Chow W. H., Chan J., Bergström A., Wolk A., Gridley G., McLaughlin J. K., Nyrén O., Adami H. O. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia. 1999;42(1):107-112.

    Not in our library10.1007/s001250051122 (opens in a new tab)

29. 29.

    Lindblad P., Wolk A., Bergström R., Persson I., Adami H. O. The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 1994;3(8):631-639.

    Not in our library

30. 30.

    Liu S., Semenciw R., Morrison H., Schanzer D., Mao Y. Kidney cancer in Canada: the rapidly increasing incidence of adenocarcinoma in adults and seniors. Can J Public Health. 1997;88(2):99-104.

    Not in our library10.1007/bf03403870 (opens in a new tab)

31. 31.

    Maclure M., Willett W. A case-control study of diet and risk of renal adenocarcinoma. Epidemiology. 1990;1(6):430-440.

    Not in our library10.1097/00001648-199011000-00004 (opens in a new tab)

32. 32.

    McCredie M., Stewart J. H. Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control. 1992;3(4):323-331.

    Not in our library10.1007/bf00146885 (opens in a new tab)

33. 33.

    McLaughlin J. K., Chow W. H., Mandel J. S., Mellemgaard A., McCredie M., Lindblad P., Schlehofer B., Pommer W., Niwa S., Adami H. O. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer. 1995;63(2):216-221.

    Not in our library10.1002/ijc.2910630212 (opens in a new tab)

34. 34.

    McLaughlin J. K., Gao Y. T., Gao R. N., Zheng W., Ji B. T., Blot W. J., Fraumeni J. F. Risk factors for renal-cell cancer in Shanghai, China. Int J Cancer. 1992;52(4):562-565.

    Not in our library10.1002/ijc.2910520411 (opens in a new tab)

35. 35.

    McLaughlin J. K., Lindblad P., Mellemgaard A., McCredie M., Mandel J. S., Schlehofer B., Pommer W., Adami H. O. International renal-cell cancer study. I. Tobacco use. Int J Cancer. 1995;60(2):194-198.

    Not in our library10.1002/ijc.2910600211 (opens in a new tab)

36. 36.

    McLaughlin J. K., Lipworth L. Epidemiologic aspects of renal cell cancer. Semin Oncol. 2000;27(2):115-123.

    Not in our library

37. 37.

    McLaughlin J. K., Mandel J. S., Blot W. J., Schuman L. M., Mehl E. S., Fraumeni J. F. A population--based case--control study of renal cell carcinoma. J Natl Cancer Inst. 1984;72(2):275-284.

    Not in our library

38. 38.

    Mellemgaard A., Engholm G., McLaughlin J. K., Olsen J. H. Risk factors for renal-cell carcinoma in Denmark. III. Role of weight, physical activity and reproductive factors. Int J Cancer. 1994;56(1):66-71.

    Not in our library10.1002/ijc.2910560113 (opens in a new tab)

39. 39.

    Mellemgaard A., Lindblad P., Schlehofer B., Bergström R., Mandel J. S., McCredie M., McLaughlin J. K., Niwa S., Odaka N., Pommer W. International renal-cell cancer study. III. Role of weight, height, physical activity, and use of amphetamines. Int J Cancer. 1995;60(3):350-354.

    Not in our library10.1002/ijc.2910600313 (opens in a new tab)

40. 40.

    Mellemgaard A., Møller H., Olsen J. H., Jensen O. M. Increased risk of renal cell carcinoma among obese women. J Natl Cancer Inst. 1991;83(21):1581-1582.

    Not in our library10.1093/jnci/83.21.1581 (opens in a new tab)

• A hint for the obesity paradox and the link between obesity, perirenal adipose tissue and Renal Cell Carcinoma progression · 2022

  Not checked

• Association between visceral adiposity and DDX11 as a predictor of aggressiveness of small clear-cell renal-cell carcinoma: a prospective clinical trial · 2021

  Not checked

• Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer‐specific survival of patients with kidney cancer · 2020

  Not checked

• Renal Cell Carcinoma and Visceral Adipose Index: a new risk parameter

  Not checked

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.